{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T15:26:34Z","timestamp":1767540394271},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11096-012-9672-9","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T01:39:34Z","timestamp":1342661974000},"page":"746-756","source":"Crossref","is-referenced-by-count":22,"title":["Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"34","author":[{"given":"Sabrina","family":"Schr\u00f6der","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Martus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Odin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"9672_CR1","unstructured":"Eggert K, Deuschl G, Gasser T, Oertel WH, Arnold G, Baas H, et al. Leitlinie Parkinson-Syndrome, 2. Ausgabe. In: Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. 3. \u00fcberarbeitete Auflage. [Parkinson\u2019s disease guideline. 2nd edn. In: Guidelines for diagnosis and therapy in neurology. 3rd revised edn.]. Stuttgart: Georg Thieme Verlag; 2005, ISBN:[3-13-132413-9]. In German."},{"issue":"2","key":"9672_CR2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1524-4733.2008.00430.x","volume":"12","author":"M Visser","year":"2009","unstructured":"Visser M, Verbaan D, van Rooden S, Marinus J, van Hilten J, Stiggelbout A. A longitudinal evaluation of health-related quality of life of patients with Parkinson\u2019s disease. Value Health. 2009;12(2):392\u20136.","journal-title":"Value Health"},{"issue":"3","key":"9672_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1353-8020(01)00044-X","volume":"8","author":"EA Chrischilles","year":"2002","unstructured":"Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL. Linking clinical variables to health-related quality of life in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2002;8(3):199\u2013209.","journal-title":"Parkinsonism Relat Disord."},{"issue":"4","key":"9672_CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s004150200032","volume":"249","author":"A Schrag","year":"2002","unstructured":"Schrag A, Ben-Shlomo Y, Quinn N. How common are complications of Parkinson\u2019s disease? J Neurol. 2002;249(4):419\u201323.","journal-title":"J Neurol."},{"key":"9672_CR5","doi-asserted-by":"crossref","unstructured":"Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL. Limitations of current Parkinson\u2019s disease therapy. Ann Neurol. 2003;53 Suppl 3:S3\u2013S12; discussion S12\u20135.","DOI":"10.1002\/ana.10513"},{"issue":"2","key":"9672_CR6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/pds.682","volume":"11","author":"O Leoni","year":"2002","unstructured":"Leoni O, Martignoni E, Cosentino M, Michielotto D, Calandrella D, Zangaglia R, et al. Drug prescribing patterns in Parkinson\u2019s disease: a pharmacoepidemiological survey in a cohort of ambulatory patients. Pharmacoepidemiol Drug Saf. 2002;11(2):149\u201357.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"10","key":"9672_CR7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/pds.1415","volume":"16","author":"S Schr\u00f6der","year":"2007","unstructured":"Schr\u00f6der S, Z\u00f6llner YF, Schaefer M. Drug related problems with Antiparkinsonian agents: consumer Internet reports versus published data. Pharmacoepidemiol Drug Saf. 2007;16(10):1161\u20136.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"3","key":"9672_CR8","first-page":"533","volume":"47","author":"CD Hepler","year":"1990","unstructured":"Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533\u201343.","journal-title":"Am J Hosp Pharm."},{"issue":"1","key":"9672_CR9","first-page":"155","volume":"7","author":"JWF Mil van","year":"2006","unstructured":"van Mil JWF, Schulz M. A review of pharmaceutical care in community pharmacy in Europe. Harv Health Policy Rev. 2006;7(1):155\u201368.","journal-title":"Harv Health Policy Rev."},{"key":"9672_CR10","doi-asserted-by":"crossref","unstructured":"Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, et al. Effect of outpatient pharmacists\u2019 non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010;7.","DOI":"10.1002\/14651858.CD000336.pub2"},{"issue":"7456","key":"9672_CR11","first-page":"709","volume":"278","author":"G Mynors","year":"2007","unstructured":"Mynors G, Jenkinson C, MacNeill V, Balcon R. A pilot evaluation of specialist community pharmacy services for patients with Parkinson\u2019s disease. Pharm J. 2007;278(7456):709\u201312.","journal-title":"Pharm J."},{"key":"9672_CR12","unstructured":"Schaefer M, Schulz M. Manuale zur Pharmazeutischen Betreuung\u2014Band 1: Grundlagen der Pharmazeutischen Betreuung [Manuals on pharmaceutical care\u2014volume 1: foundations of pharmaceutical care]. Govi-Verlag; 2000. ISBN:978-3-7741-0844-8. In German."},{"key":"9672_CR13","unstructured":"Barmer Ersatzkasse (BEK), Deutschen Apothekerverband e.V. (DAV). Vereinbarung zwischen der Barmer Ersatzkasse (BEK) und dem Deutschen Apothekerverband e.V. (DAV) zur Intensivierung der Kooperation bei der qualit\u00e4tsorientierten Versorgung der Versicherten [Agreement between Barmer Ersatzkasse (BEK) and the German Pharmacists\u2019 Association (DAV) to intensify cooperation in the quality-oriented care of insured patients]. 2004. In German."},{"issue":"4","key":"9672_CR14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s11096-011-9526-x","volume":"33","author":"S Schr\u00f6der","year":"2011","unstructured":"Schr\u00f6der S, Martus P, Odin P, Schaefer M. Drug-related problems in Parkinson\u2019s disease: the role of community pharmacists in primary care. Int J Clin Pharm. 2011;33(4):674\u201382.","journal-title":"Int J Clin Pharm."},{"issue":"3","key":"9672_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181\u20134.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"9672_CR16","unstructured":"World Medical Association (WMA). Declaration of Helsinki. Ethical principles for medical research involving human subjects. 52nd WMA General Assembly, Edinburgh, Scotland, Oct 2000 (updated at 53rd WMA General Assembly, Washington, DC, USA, Oct 2002)."},{"key":"9672_CR17","unstructured":"Apothekenbetriebsordnung (ApBetrO). Verordnung \u00fcber den Betrieb von Apotheken [Ordinance on the operation of pharmacies]. BGBl. 1995;51:1195; amended in BGBI. 2005;34:1645. In German."},{"key":"9672_CR18","unstructured":"Arzneimittelgesetz (AMG). Gesetz \u00fcber den Verkehr mit Arzneimitteln [Law on the marketing of drugs]. BGBl. 2005;73:3394. In German."},{"issue":"5","key":"9672_CR19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427\u201342.","journal-title":"Neurology."},{"key":"9672_CR20","unstructured":"Martus P. Entwicklung einfacher Scores f\u00fcr Dimensionen der Symptomschwere bei Morbus Parkinson auf Basis der Faktorscores des PS-23 Fragebogeninstruments [Development of simple scores for dimensions of symptom severity in Parkinson\u2019s disease based on the factor scores of the PS-23 questionnaire instrument]. Technical report from the Charit\u00e9 Centrum f\u00fcr Therapieforschung [report on the internet]. 2010. Cited June 2012. Available from: http:\/\/www.medizin.uni-tuebingen.de\/uktmedia\/Einrichtungen\/Institute\/Institut+fuer+Medizinische+Biometrie\/PDF_Archiv\/Martus+report+PS_23.pdf . In German."},{"issue":"6","key":"9672_CR21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/08870449708406741","volume":"12","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: development and validation of a short-form Parkinson\u2019s disease questionnaire. Psychol Health. 1997;12(6):805\u201314.","journal-title":"Psychol Health."},{"issue":"3","key":"9672_CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"The EuroQol Group","year":"1990","unstructured":"The EuroQol Group. EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208.","journal-title":"Health Policy."},{"key":"9672_CR23","doi-asserted-by":"crossref","unstructured":"Brooks R, Rabin R, de Charro F. The measurement and valuation of health status using EQ-5D: a European perspective. Boston: Kluwer Academic Publishers; 2003. p. 324. ISBN:1-4020-1214-4.","DOI":"10.1007\/978-94-017-0233-1"},{"issue":"7","key":"9672_CR24","first-page":"244","volume":"30","author":"O Schwalbe","year":"2007","unstructured":"Schwalbe O, Freiberg I, Kloft C. Die Beers-Liste: Ein Instrument zur Optimierung der Arzneimitteltherapie geriatrischer Patienten [The Beers criteria: an instrument to optimise the pharmacotherapy of geriatric patients]. Med Monatsschr Pharm. 2007;30(7):244\u20138.","journal-title":"Med Monatsschr Pharm."},{"issue":"9","key":"9672_CR25","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","volume":"151","author":"MH Beers","year":"1991","unstructured":"Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151(9):1825\u201332.","journal-title":"Arch Intern Med."},{"key":"9672_CR26","first-page":"103","volume":"7","author":"S Schr\u00f6der","year":"2011","unstructured":"Schr\u00f6der S, Kuessner D, Arnold G, Z\u00f6llner Y, Jones E, Schaefer M. Do neurologists in Germany adhere to the national Parkinson\u2019s disease guideline? Neuropsychiatr Dis Treat. 2011;7:103\u201310.","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"7","key":"9672_CR27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00005650-199007000-00008","volume":"28","author":"MH Liang","year":"1990","unstructured":"Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care. 1990;28(7):632\u201342.","journal-title":"Med Care."},{"issue":"7","key":"9672_CR28","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","volume":"21","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson\u2019s disease: the NMSQuest study. Mov Disord. 2006;21(7):916\u201323.","journal-title":"Mov Disord."},{"issue":"5","key":"9672_CR29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.parkreldis.2006.11.009","volume":"13","author":"MA Lee","year":"2007","unstructured":"Lee MA, Prentice WM, Hildreth AJ, Walker RW. Measuring symptom load in idiopathic Parkinson\u2019s disease. Parkinsonism Relat Disord. 2007;13(5):284\u20139.","journal-title":"Parkinsonism Relat Disord."},{"issue":"1","key":"9672_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1211\/0022357055551","volume":"13","author":"EE Roughead","year":"2005","unstructured":"Roughead EE, Semple SJ, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes. Int J Pharm Pract. 2005;13(1):53\u201370.","journal-title":"Int J Pharm Pract."},{"key":"9672_CR31","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer\u2019s handbook [book on the internet]. 2008. Cited Oct 2011. Available from: http:\/\/www.sign.ac.uk\/guidelines\/fulltext\/50\/annexb.html ."},{"issue":"10","key":"9672_CR32","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1345\/aph.1K151","volume":"41","author":"M Machado","year":"2007","unstructured":"Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569\u201378.","journal-title":"Ann Pharmacother."},{"issue":"9","key":"9672_CR33","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1345\/aph.1K618","volume":"42","author":"M Machado","year":"2008","unstructured":"Machado M, Nassor N, Bajcar JM, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother. 2008;42(9):1195\u2013207.","journal-title":"Ann Pharmacother."},{"issue":"9","key":"9672_CR34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2165\/00002512-200623090-00001","volume":"23","author":"CH Dowding","year":"2006","unstructured":"Dowding CH, Shenton CL, Salek SS. A review of the health-related quality of life and economic impact of Parkinson\u2019s disease. Drugs Aging. 2006;23(9):693\u2013721.","journal-title":"Drugs Aging."},{"issue":"1","key":"9672_CR35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ageing\/29.1.41","volume":"29","author":"JE Harrison","year":"2000","unstructured":"Harrison JE, Preston S, Blunt SB. Measuring symptom change in patients with Parkinson\u2019s disease. Age Ageing. 2000;29(1):41\u20135.","journal-title":"Age Ageing."},{"issue":"2","key":"9672_CR36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.parkreldis.2006.07.009","volume":"13","author":"M Reuther","year":"2007","unstructured":"Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K, et al. Assessing health-related quality of life in patients with Parkinson\u2019s disease in a prospective longitudinal study. Parkinsonism Relat Disord. 2007;13(2):108\u201314.","journal-title":"Parkinsonism Relat Disord."},{"issue":"6","key":"9672_CR37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/mds.22438","volume":"24","author":"A Schrag","year":"2009","unstructured":"Schrag A, Spottke A, Quinn NP, Dodel R. Comparative responsiveness of Parkinson\u2019s disease scales to change over time. Mov Disord. 2009;24(6):813\u20138.","journal-title":"Mov Disord."},{"issue":"4","key":"9672_CR38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11136-010-9615-7","volume":"19","author":"N Luo","year":"2010","unstructured":"Luo N, Ng WY, Lau PN, Au WL, Tan LC. Responsiveness of the EQ-5D and 8-item Parkinson\u2019s Disease Questionnaire (PDQ-8) in a 4-year follow-up study. Qual Life Res. 2010;19(4):565\u20139.","journal-title":"Qual Life Res."},{"issue":"3","key":"9672_CR39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/B:PHAR.0000026811.37414.4f","volume":"26","author":"NM Kheir","year":"2004","unstructured":"Kheir NM, van Mil JW, Shaw JP, Sheridan JL. Health-related quality of life measurement in pharmaceutical care. Targeting an outcome that matters. Pharm World Sci. 2004;26(3):125\u20138.","journal-title":"Pharm World Sci."},{"issue":"3","key":"9672_CR40","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1345\/aph.1H473","volume":"41","author":"E Jano","year":"2007","unstructured":"Jano E, Aparasu RR. Healthcare outcomes associated with beers\u2019 criteria: a systematic review. Ann Pharmacother. 2007;41(3):438\u201347.","journal-title":"Ann Pharmacother."},{"issue":"3","key":"9672_CR41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.18553\/jmcp.2009.15.3.262","volume":"15","author":"NH Al-Momany","year":"2009","unstructured":"Al-Momany NH, Al-Bakri AG, Makahleh ZM, Wazaify MM. Adherence to international antimicrobial prophylaxis guidelines in cardiac surgery: a Jordanian study demonstrates need for quality improvement. J Manag Care Pharm. 2009;15(3):262\u201371.","journal-title":"J Manag Care Pharm."},{"issue":"1","key":"9672_CR42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1211\/ijpp.15.1.0007","volume":"15","author":"CM Bond","year":"2007","unstructured":"Bond CM, Fish A, Porteous TH, Reid JP, Scott A, Antonazzo E. A randomised controlled trial of the effects of note-based medication review by community pharmacists on prescribing of cardiovascular drugs in general practice. Int J Pharm Pract. 2007;15(1):39\u201346.","journal-title":"Int J Pharm Pract."}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-012-9672-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-012-9672-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-012-9672-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T02:54:31Z","timestamp":1642820071000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-012-9672-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,19]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["9672"],"URL":"https:\/\/doi.org\/10.1007\/s11096-012-9672-9","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,19]]}}}